Quantcast

Industry news that matters to you.  Learn more

Scienion, Courtagen Ink Deal for Biochip Production

Scienion US, Inc. announced recently that Courtagen Life Sciences, Inc. – a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry – will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.

Courtagen Submits Pre-IDE Information Package for the Avantra Q400 Workstation and QPDx BioChip

Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that the company has submitted its first pre- IDE (Investigational Device Exemption) information package to the U.S. Food and Drug Administration for the Company’s Avantra® Q400 BioMarker Workstation and QPDX® BioChip for the measurement of C-reactive protein (CRP). Courtagen is also pursuing a CE Mark Approval for the European Union.

Proteome Sciences Licenses Stroke Biomarker Portfolio to Randox

Proteome Sciences plc (“Proteome Sciences”), a global leader in protein biomarkers has today granted a non-exclusive license to Randox Laboratories (“Randox”) of Crumlin, UK for its portfolio of stroke biomarkers.

GeneNews Enters Into MOU With Shanghai Biochip to Establish First Sentinel Centre for Personalized Medicine

GeneNews Limited, a molecular diagnostics company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has signed a memorandum of understanding (“MOU”) with Shanghai Biochip Co. Ltd. (“SBC”), a leading Chinese engineering centre for advanced microarray and gene expression profiling technologies, to enter into a strategic alliance to establish the first Sentinel Centre for Personalized Medicine in China.

Avantra Biosciences Launches Multiplex System for Faster, Easier Quantification of Cancer Protein Biomarkers

Avantra Biosciences, a leading innovator in protein diagnostics, announced today their first shipments of the new Q400 Biomarker Workstation and the innovative Angio Qx BioChip Immunoassay. The system provides quantitative protein biomarker results for ten analytes in less than an hour, requiring less than five minutes for sample preparation. Multiplex protein assays can be helpful in evaluating the association between elevated protein levels, patient phenotype and drug response.